INVO Bioscience, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by INVO Bioscience, Inc. (trading symbol: INVO) on October 23, 2023. The report addresses a corporate governance event regarding the rescheduling of the company's 2023 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a procedural announcement and contains no financial data.
Material Changes
The primary material change is the rescheduling of the 2023 Annual Meeting of Shareholders:
- Previous Date: November 16, 2023
- New Date: December 26, 2023
- Reasoning: The new date is more than 30 days after the one-year anniversary of the 2022 annual meeting (held October 12, 2022).
Guidance, Outlook, and Deadlines
Management has established specific deadlines for shareholder actions due to the rescheduling:
- Shareholder Proposals (Rule 14a-8): Must be received by the close of business on November 3, 2023.
- Business to be Brought Before the Meeting: Shareholders must notify the Company by the close of business on November 3, 2023.
- Submission Address: INVO Bioscience, Inc., 5582 Broadcast Court, Sarasota, FL 34240, Attention: Corporate Secretary.
Key Facts for Investor Verification
- Verify the new Annual Meeting date of December 26, 2023, in upcoming proxy materials.
- Confirm the November 3, 2023 deadline for submitting shareholder proposals or notices of business.
- Note that the filing contains no financial performance updates or operational guidance.